397 related articles for article (PubMed ID: 14986248)
1. The epidemiology of fluoroquinolone-resistant Neisseria gonorrhoeae in Hawaii, 2001.
Newman LM; Wang SA; Ohye RG; O'Connor N; Lee MV; Weinstock HS
Clin Infect Dis; 2004 Mar; 38(5):649-54. PubMed ID: 14986248
[TBL] [Abstract][Full Text] [Related]
2. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men--United States, 2003, and revised recommendations for gonorrhea treatment, 2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(16):335-8. PubMed ID: 15123985
[TBL] [Abstract][Full Text] [Related]
3. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(46):1041-4. PubMed ID: 12487525
[TBL] [Abstract][Full Text] [Related]
4. Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Sep; 49(37):833-7. PubMed ID: 11012233
[TBL] [Abstract][Full Text] [Related]
5. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1994 May; 43(18):325-7. PubMed ID: 8164636
[TBL] [Abstract][Full Text] [Related]
6. Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001.
Wang SA; Lee MV; O'Connor N; Iverson CJ; Ohye RG; Whiticar PM; Hale JA; Trees DL; Knapp JS; Effler PV; Weinstock HS
Clin Infect Dis; 2003 Sep; 37(6):849-52. PubMed ID: 12955650
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology of recently emergent ciprofloxacin-resistant Neisseria gonorrhoeae in South Africa.
Moodley P; Martin IM; Pillay K; Ison CA; Sturm AW
Sex Transm Dis; 2006 Jun; 33(6):357-60. PubMed ID: 16572037
[TBL] [Abstract][Full Text] [Related]
8. Resistance trends in Neisseria gonorrhoeae in southwestern Ohio.
Herchline TE; Inkrott BP
Sex Transm Dis; 2010 Feb; 37(2):121-2. PubMed ID: 19901861
[TBL] [Abstract][Full Text] [Related]
9. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Apr; 56(14):332-6. PubMed ID: 17431378
[TBL] [Abstract][Full Text] [Related]
10. Fluoroquinolone-resistant Neisseria gonorrhoeae--San Diego, California, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 May; 47(20):405-8. PubMed ID: 9622458
[TBL] [Abstract][Full Text] [Related]
11. [Ciprofloxacin resistance of Neisseria gonorrhoeae according to sexual habits].
García S; Casco R; Perazzi B; De Mier C; Vay C; Famiglietti A
Medicina (B Aires); 2008; 68(5):358-62. PubMed ID: 18977704
[TBL] [Abstract][Full Text] [Related]
12. RE: Ciprofloxacin resistance in Great Yarmouth and Waveney district.
Harry TC
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):216-7. PubMed ID: 16441638
[No Abstract] [Full Text] [Related]
13. [The rise in fluoroquinolone-resistant Neisseria gonorrhoeae among people attending the Municipal Health Service's clinic for sexually transmitted diseases in Amsterdam, the Netherlands; cefotaxime now first-choice treatment for uncomplicated gonorrhoea].
Kolader M; Peerbooms PG; Vader PC; van Bergen JE; Fennema JS; de Vries HJ
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2129-32. PubMed ID: 15553358
[TBL] [Abstract][Full Text] [Related]
14. Fluoroquinolone resistance in Neisseria gonorrhoeae--Colorado and Washington, 1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1995 Oct; 44(41):761-4. PubMed ID: 7565558
[TBL] [Abstract][Full Text] [Related]
15. Trends in antimicrobial susceptibility of Neisseria gonorrhoeae in Israel, 2002 to 2007, with special reference to fluoroquinolone resistance.
Dan M; Mor Z; Gottliev S; Sheinberg B; Shohat T
Sex Transm Dis; 2010 Jul; 37(7):451-3. PubMed ID: 20562585
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin resistance in Neisseria gonorrhoeae: trends in Hawaii, 1997-2002.
Katz AR; Lee MV; Ohye RG; Whiticar PM; Effler PV
Lancet; 2003 Aug; 362(9382):495. PubMed ID: 12927447
[No Abstract] [Full Text] [Related]
17. Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993-2002: continuous increasing of ciprofloxacin-resistant isolates.
Tanaka M; Nakayama H; Notomi T; Irie S; Tsunoda Y; Okadome A; Saika T; Kobayashi I
Int J Antimicrob Agents; 2004 Sep; 24 Suppl 1():S15-22. PubMed ID: 15364300
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003.
Bauer HM; Mark KE; Samuel M; Wang SA; Weismuller P; Moore D; Gunn RA; Peter C; Vannier A; DeAugustine N; Klausner JD; Knapp JS; Bolan G
Clin Infect Dis; 2005 Sep; 41(6):795-803. PubMed ID: 16107976
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of ciprofloxacin-resistant Neisseria gonorrhoeae in Northern Taiwan.
Hsueh PR; Tseng SP; Teng LJ; Ho SW
Clin Infect Dis; 2005 Jan; 40(1):188-92. PubMed ID: 15614711
[TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolone resistance in Neisseria gonorrhoeae.
Knapp JS; Fox KK; Trees DL; Whittington WL
Emerg Infect Dis; 1997; 3(1):33-9. PubMed ID: 9126442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
